This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Dec;1(8):E195-7.

doi: 10.1038/70223.

SMAD destruction turns off signalling

C H Heldin, P ten Dijke

PMID: 10587654
DOI: 10.1038/70223

Comment

SMAD destruction turns off signalling

C H Heldin et al. Nat Cell Biol. 1999 Dec.

. 1999 Dec;1(8):E195-7.

doi: 10.1038/70223.

Authors

C H Heldin, P ten Dijke

PMID: 10587654
DOI: 10.1038/70223

No abstract available

PubMed Disclaimer

Comment on

Ubiquitin-dependent degradation of TGF-beta-activated smad2.
Lo RS, Massagué J. Lo RS, et al. Nat Cell Biol. 1999 Dec;1(8):472-8. doi: 10.1038/70258. Nat Cell Biol. 1999. PMID: 10587642

Similar articles

Ubiquitin-dependent degradation of TGF-beta-activated smad2.
Lo RS, Massagué J. Lo RS, et al. Nat Cell Biol. 1999 Dec;1(8):472-8. doi: 10.1038/70258. Nat Cell Biol. 1999. PMID: 10587642
Ubiquitin signalling: what's in a chain?
Hochstrasser M. Hochstrasser M. Nat Cell Biol. 2004 Jul;6(7):571-2. doi: 10.1038/ncb0704-571. Nat Cell Biol. 2004. PMID: 15232583 No abstract available.
The ubiquitin-proteasome pathway: on protein death and cell life.
Ciechanover A. Ciechanover A. EMBO J. 1998 Dec 15;17(24):7151-60. doi: 10.1093/emboj/17.24.7151. EMBO J. 1998. PMID: 9857172 Free PMC article. Review. No abstract available.
Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J, Attisano L. Xu J, et al. Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4820-5. doi: 10.1073/pnas.97.9.4820. Proc Natl Acad Sci U S A. 2000. PMID: 10781087 Free PMC article.
The Smad pathway.
Wrana JL, Attisano L. Wrana JL, et al. Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):5-13. doi: 10.1016/s1359-6101(99)00024-6. Cytokine Growth Factor Rev. 2000. PMID: 10708948 Review.

See all similar articles

Cited by

Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells.
Natsuizaka M, Ohashi S, Wong GS, Ahmadi A, Kalman RA, Budo D, Klein-Szanto AJ, Herlyn M, Diehl JA, Nakagawa H. Natsuizaka M, et al. Carcinogenesis. 2010 Aug;31(8):1344-53. doi: 10.1093/carcin/bgq108. Epub 2010 May 31. Carcinogenesis. 2010. PMID: 20513670 Free PMC article.
Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling.
Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. Guo X, et al. Genes Dev. 2008 Jan 1;22(1):106-20. doi: 10.1101/gad.1590908. Genes Dev. 2008. PMID: 18172167 Free PMC article.
Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
Pierreux CE, Nicolás FJ, Hill CS. Pierreux CE, et al. Mol Cell Biol. 2000 Dec;20(23):9041-54. doi: 10.1128/MCB.20.23.9041-9054.2000. Mol Cell Biol. 2000. PMID: 11074002 Free PMC article.
Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.
Guo X, Waddell DS, Wang W, Wang Z, Liberati NT, Yong S, Liu X, Wang XF. Guo X, et al. Oncogene. 2008 Dec 11;27(58):7235-47. doi: 10.1038/onc.2008.337. Epub 2008 Sep 15. Oncogene. 2008. PMID: 18794808 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Molecular Biology Databases
- GlyGen glycoinformatics resource